Product
F 18 T807 Flortaucipir
1 clinical trial
1 indication
Indication
Alzheimer's diseaseClinical trial
Imaging of Brain Structural/Functional Connectivity and Amyloid and Tau Lesions in APOE4 Carriers. (IND 123119, Protocol Z)Status: Withdrawn, Estimated PCD: 2022-10-11